SMTL ID : 3wzk.1 (1 other biounit)

CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: P.199, S.267, I.268 Ligand excluded by PLIP

1 x O23: N-cyclopropyl-4-{8-[(thiophen-2-ylmethyl)amino]imidazo[1,2-a]pyrazin-3-yl}benzamide(Non-covalent)

O23.2: 17 residues within 4Å: Chain A: K.15, I.17, V.25, Q.27, A.37, K.39, E.57, L.61, M.88, E.89, C.90, G.91, N.92, I.93, L.140, I.149, D.150 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.17, A:V.25, A:V.25, A:E.57, A:L.61, A:I.149, A:I.149, A:D.150 Hydrogen bonds: A:G.91, A:G.91, A:I.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kusakabe, K. et al., Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity. J.Med.Chem. (2015)

Release Date

2015-02-11

Peptides

Dual specificity protein kinase TTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase TTK

Related Entries With Identical Sequence